via National Human Genome Research Institute
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has the potential to protect us against serious life-limiting diseases such as cancer and dementia
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia.
Cancer and neurodegeneration are two major health challenges currently affecting the population, and they constitute two sides of the same coin – one is caused by uncontrolled cell proliferation due to genome damage, and the other is caused by excessive genome damage that causes cell death. This new pathway impacts both and offers new therapeutic opportunities to help the fight against disease.
Published in Nature Communications, the research found that when cells in our body read DNA to build proteins, they often make mistakes that can damage our genome, causing disease such as cancer and dementia. However, by investigating how cells fix damage in the DNA to keep us healthy, scientists have discovered the benefits of three proteins working together as a team. The three proteins, called USP11, KEAP1 and SETX, receive instructions from their coach to direct their function in space and time with remarkable harmony, to keep our DNA healthy.
By understanding how cells protect themselves from these mistakes and thus preventing diseases, scientists are able to modify the behaviour of these proteins to promote the health and wellbeing of people.
Findings from this study will enable scientists to develop diagnostic tests and drugs to target one or more of the proteins in the pathway for the early detection and treatment of certain types of cancer and neurological disease. Developing new drugs to regulate the level of one or more of these proteins is expected to offer new treatments for cancer and dementia.
The findings are important and significant, this is because we are now at the stage where we could make drugs to control this modification. This would be useful in killing cells, which is what we do when we treat elderly people for cancer. The other application would be to reduce the level of genome damage, which could be beneficial for other ageing associated disorders like dementia.
Original Article: New gene therapy pathway could protect us from cancer and dementia
More from: University of Sheffield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy pathway
- Significant step on path to developing Alzheimer's therapyon August 1, 2022 at 6:40 am
A brain protein with high potential to delay or reverse the onset of Alzheimer's disease has been exploited by University of Otago researchers.
- Sarepta to ask FDA for accelerated approval of Duchenne gene therapyon July 29, 2022 at 8:46 am
After discussions with the FDA, the biotech aims to submit an application this fall — sooner than expected and ahead of a Phase 3 study that’s now ongoing.
- Enzyme that Promotes Diet-Induced Obesity Could Point to Inhibitor Therapyon July 29, 2022 at 5:07 am
“Our data demonstrate that aldose reductase gene expression increases in scAT of obese humans ... “These data unveil new opportunities to target these pathways to combat obesity.” Senescence is a ...
- FDA Reviewing Tofersen for SOD1-ALS; Decision Expected in Januaryon July 27, 2022 at 6:15 am
The FDA agreed to review Biogen's tofersen therapy for treating amyotrophic lateral sclerosis associated with mutations in the SOD1 gene.
- Challenges in Neuroprotective Nanomedicine Development: Progress Towards Noninvasive Gene Therapy of Glaucomaon July 14, 2022 at 5:01 pm
Common approaches of neuroprotection include stimulating molecular pathways that promote neuron ... often targeted to specific ocular tissues. Gene therapy for glaucoma is a treatment that aims ...
Go deeper with Google Headlines on:
Gene therapy pathway
Go deeper with Bing News on:
Gene therapy
- Gene Therapy for Hemophilia B Shows Promiseon August 1, 2022 at 6:24 am
A small study finds that an adeno-associated virus gene therapy eliminated both spontaneous bleeding and the need for factor IX prophylaxis in patients with hemophilia B.
- Helping cells become better protein factories could improve gene therapies and other treatments – a new technique shows howon August 1, 2022 at 5:27 am
Gene therapies and vaccines are often injected into muscle cells that are inefficient at producing desired proteins. Making them work more like liver cells could lead to better treatment outcomes.
- Gene therapy firm fighting blindness expands into new space in RTPon August 1, 2022 at 4:38 am
Over the last two years, the Durham company has grown to about 35 full-time employees and could surpass 40 by the end of this year.
- Sarepta to ask FDA for accelerated approval of Duchenne gene therapyon July 29, 2022 at 8:46 am
After discussions with the FDA, the biotech aims to submit an application this fall — sooner than expected and ahead of a Phase 3 study that’s now ongoing.
- Sarepta Will Seek Approval of Gene Therapy Before Completing Phase 3 Trialon July 29, 2022 at 7:50 am
Sarepta (ticker: SRPT) had said as recently as July 6 that it was in talks with the FDA about submitting the gene therapy, known as SRP-9001, for accelerated approval. Analysts, however, had thought ...
